万泰生物高管拟减持不超过40万股股份

新京报12-21

新京报讯 12月20日，万泰生物发布公告，公司副总经理赵灵芝计划在本公告披露之日起15个交易日后的3个月内，通过集中竞价交易方式减持公司股份不超过40万股，占公司总股本的0.0316%。目前，赵灵芝持有公司股份169.53万股，占公司总股本的0.134%，其中部分股份来源于公司首次公开发行股票并上市前取得的股份及上市后公司实施股利分配方案后取得的股份。减持计划将根据市场情况及公司股价选择实施。文章...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2493130426?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-21 00:04","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2493130426","market":"sh","top_or_hot":-1,"title":"万泰生物高管拟减持不超过40万股股份","media":"新京报","content":"<div>\n<p>新京报讯 12月20日，万泰生物发布公告，公司副总经理赵灵芝计划在本公告披露之日起15个交易日后的3个月内，通过集中竞价交易方式减持公司股份不超过40万股，占公司总股本的0.0316%。目前，赵灵芝持有公司股份169.53万股，占公司总股本的0.134%，其中部分股份来源于公司首次公开发行股票并上市前取得的股份及上市后公司实施股利分配方案后取得的股份。减持计划将根据市场情况及公司股价选择实施。文章...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002047ab879414&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>万泰生物高管拟减持不超过40万股股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n万泰生物高管拟减持不超过40万股股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-21 00:04 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002047ab879414&s=b><strong>新京报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>新京报讯 12月20日，万泰生物发布公告，公司副总经理赵灵芝计划在本公告披露之日起15个交易日后的3个月内，通过集中竞价交易方式减持公司股份不超过40万股，占公司总股本的0.0316%。目前，赵灵芝持有公司股份169.53万股，占公司总股本的0.134%，其中部分股份来源于公司首次公开发行股票并上市前取得的股份及上市后公司实施股利分配方案后取得的股份。减持计划将根据市场情况及公司股价选择实施。文章...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002047ab879414&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002047ab879414&s=b","article_id":"2493130426","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002047ab879414&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2493130426","pubTimestamp":1734710653,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"新京报讯 12月20日，万泰生物发布公告，公司副总经理赵灵芝计划在本公告披露之日起15个交易日后的3个月内，通过集中竞价交易方式减持公司股份不超过40万股，占公司总股本的0.0316%。目前，赵灵芝持有公司股份169.53万股，占公司总股本的0.134%，其中部分股份来源于公司首次公开发行股票并上市前取得的股份及上市后公司实施股利分配方案后取得的股份。减持计划将根据市场情况及公司股价选择实施。文章来源：新京报原标题：万泰生物高管拟减持不超过40万股股份","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603392":"万泰生物","BK0239":"医药制造"},"translate_title":"Wantai Biotech executives plan to reduce their holdings by no more than 400,000 shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603392":1},"content_text":"新京报讯 12月20日，万泰生物发布公告，公司副总经理赵灵芝计划在本公告披露之日起15个交易日后的3个月内，通过集中竞价交易方式减持公司股份不超过40万股，占公司总股本的0.0316%。目前，赵灵芝持有公司股份169.53万股，占公司总股本的0.134%，其中部分股份来源于公司首次公开发行股票并上市前取得的股份及上市后公司实施股利分配方案后取得的股份。减持计划将根据市场情况及公司股价选择实施。文章来源：新京报原标题：万泰生物高管拟减持不超过40万股股份","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2493130426"}